Literature DB >> 17037577

Efficacy of an inactivated PRRSV vaccine: induction of virus-neutralizing antibodies and partial virological protection upon challenge.

Gerald Misinzo1, Peter L Delputte, Peter Meerts, Christa Drexler, Hans J Nauwynck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17037577      PMCID： PMC7122804          DOI： 10.1007/978-0-387-33012-9_81

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  19 in total

1.  Evaluation of protective immunity in gilts inoculated with the NADC-8 isolate of porcine reproductive and respiratory syndrome virus (PRRSV) and challenge-exposed with an antigenically distinct PRRSV isolate.

Authors:  K M Lager; W L Mengeling; S L Brockmeier
Journal:  Am J Vet Res       Date:  1999-08       Impact factor: 1.156

2.  Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations.

Authors:  Henriette S Nielsen; Martin B Oleksiewicz; Roald Forsberg; Tomasz Stadejek; Anette Bøtner; Torben Storgaard
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

3.  Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity.

Authors:  F A Osorio; J A Galeota; E Nelson; B Brodersen; A Doster; R Wills; F Zuckermann; W W Laegreid
Journal:  Virology       Date:  2002-10-10       Impact factor: 3.616

4.  Involvement of the matrix protein in attachment of porcine reproductive and respiratory syndrome virus to a heparinlike receptor on porcine alveolar macrophages.

Authors:  P L Delputte; N Vanderheijden; H J Nauwynck; M B Pensaert
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages.

Authors:  Nathalie Vanderheijden; Peter L Delputte; Herman W Favoreel; Joël Vandekerckhove; Jozef Van Damme; Peter A van Woensel; Hans J Nauwynck
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy.

Authors:  G Labarque; K Van Reeth; H Nauwynck; C Drexler; S Van Gucht; M Pensaert
Journal:  Vaccine       Date:  2004-10-22       Impact factor: 3.641

7.  Effect on viraemia of an American and a European serotype PRRSV vaccine after challenge with European wild-type strains of the virus.

Authors:  P A van Woensel; K Liefkens; S Demaret
Journal:  Vet Rec       Date:  1998-05-09       Impact factor: 2.695

8.  Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell line.

Authors:  H S Kim; J Kwang; I J Yoon; H S Joo; M L Frey
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.

Authors:  D Nilubol; K B Platt; P G Halbur; M Torremorell; D L Harris
Journal:  Vet Microbiol       Date:  2004-08-19       Impact factor: 3.293

10.  Effects of origin and state of differentiation and activation of monocytes/macrophages on their susceptibility to porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  X Duan; H J Nauwynck; M B Pensaert
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574
View more
  5 in total

1.  The crystal structure of porcine reproductive and respiratory syndrome virus nonstructural protein Nsp1beta reveals a novel metal-dependent nuclease.

Authors:  Fei Xue; Yuna Sun; Liming Yan; Cong Zhao; Ji Chen; Mark Bartlam; Xuemei Li; Zhiyong Lou; Zihe Rao
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

2.  Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.

Authors:  Jung-Ah Lee; Byungjoon Kwon; Fernando A Osorio; Asit K Pattnaik; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

3.  The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods.

Authors:  Hyunil Kim; Hye Kwon Kim; Jung Ho Jung; Yoo Jung Choi; Jiho Kim; Chang Gyu Um; Su Bin Hyun; Sungho Shin; Byeongchun Lee; Goo Jang; Bo Kyu Kang; Hyoung Joon Moon; Dae Sub Song
Journal:  Virol J       Date:  2011-06-27       Impact factor: 4.099

4.  An integrated analysis of membrane remodeling during porcine reproductive and respiratory syndrome virus replication and assembly.

Authors:  Wei Zhang; Keren Chen; Xueqing Zhang; Chunhe Guo; Yaosheng Chen; Xiaohong Liu
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

5.  Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets.

Authors:  Kairat Tabynov; Abylay Sansyzbay; Zhanara Tulemissova; Kaissar Tabynov; Santosh Dhakal; Aigul Samoltyrova; Gourapura J Renukaradhya; Muratbay Mambetaliyev
Journal:  Vet Microbiol       Date:  2016-07-01       Impact factor: 3.293
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.